SPHERE - Study of Perinatal, paediatric and adolescent Health : Epidemiological Research and Evaluation
Equipe constitutive du CERPOP, UMR 1295, unité mixte de recherche Inserm – Université Toulouse III Paul Sabatier



 

2022

  1. Bayoumeu F, Vayssière C, Linet T, Agostini A, Benhamou D. L’emploi de la ropivacaïne comme anesthésique local pour le bloc paracervical n’est pas à recommander, de même que celui de la levobupivacaine ou de la bupivacaine. Gynecol Obstet Fertil Senol. 2022 Jan;50(1):98-99. French. doi: 10.1016/j.gofs.2021.08.005.
     
  2. Chevallier M, Debillon T, Darlow BA, Synnes AR, Pierrat V, Hurrion E, Yang J, Ego A, Ancel PY, Lui K, Shah PS, Luu TM; Australian and New Zealand Neonatal Network (ANZNN); Canadian Neonatal Network (CNN); Canadian Neonatal Follow-Up Network (CNFUN); Etude Epidémiologique sur les Petits Ages Gestationnels (EPIPAGE-2) Investigators (Alberge C, Arnaud C, Vayssière C collaborators). Mortality and significant neurosensory impairment in preterm infants: an international comparison. Arch Dis Child Fetal Neonatal Ed. 2022 May;107(3):317-323. doi: 10.1136/archdischild-2021-322288.
     
  3. Dubucs C, Groussolles M, Ousselin J, Sartor A, Van Acker N, Vayssière C, Pasquier C, Reyre J, Batlle L, Favarel Clinical Research Associate S, Duchanois Midwife D, Jauffret Clinical Research Associate V, Courtade-Saïdi M, Aziza J. Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death. Hum Pathol. 2022 Mar;121:46-55. doi: 10.1016/j.humpath.2021.12.012. . doi: 10.1016/j.humpath.2021.12.012.
     
  4. Groussolles M, Winer N, Sentilhes L, Biquart F, Massoud M, Vivanti AJ, Bouchghoul H, Rozenberg P, Olivier P, Desbriere R, Chauleur C, Perrotin F, Coatleven F, Fuchs F, Bretelle F, Tsatsaris V, Salomon LJ, Sananes N, Kayem G, Houflin-Debarge V, Schmitz T, Benoist G, Arnaud C, Ehlinger V, Vayssière C; Groupe de Recherche en Gynecologie Obstétrique. Arabin pessary to prevent adverse perinatal outcomes in twin pregnancies with a short cervix: a multicenter randomized controlled trial (PESSARONE). Am J Obstet Gynecol. 2022 Feb 3:S0002-9378(22)00098-9. doi: 10.1016/j.ajog.2022.01.038. Epub ahead of print.
     
  5. Offringa Y, Paret L, Vayssiere C, Parant O, Loussert L, Guerby P. Second stage cesarean section and the risk of preterm birth in subsequent pregnancies. Int J Gynaecol Obstet. 2022 Mar 21. doi: 10.1002/ijgo.14186. Epub ahead of print.
     
  6. Quibel T, Winer N, Bussières L, Vayssière C, Deruelle P, Defrance M, Rozenberg P, Bouyer J, Dupuis N, Renaudin B, Dugave L, Banaszkiewicz N, Garabedian C, Ville Y. Impact of COVID-19-Related Lockdown on Delivery and Perinatal Outcomes: A Retrospective Cohort Study. J Clin Med. 2022 Jan 30;11(3):756. doi: 10.3390/jcm11030756.

2021

  1. Cadoret F, Guerby P, Cavaignac-Vitalis M, Vayssiere C, Parant O, Vidal F. Expectant management in HELLP syndrome: predictive factors of disease evolution. J Matern Fetal Neonatal Med. 2021 Dec;34(24):4029-4034. doi: 10.1080/14767058.2019.1702956.
     
  2. Garabedian C, Dupuis N, Vayssière C, Bussières L, Ville Y, Renaudin B, Dugave L, Winer N, Banaszkiewicz N, Rozenberg P, Defrance M, Legris ML, Quibel T, Deruelle P. Impact of COVID-19 Lockdown on Preterm Births, Low Birthweights and Stillbirths: A Retrospective Cohort Study. J Clin Med. 2021 Nov 30;10(23):5649. doi: 10.3390/jcm10235649.
     
  3. Gaudineau A, Senat MV, Ehlinger V, Gallini A, Morin M, Olivier P, Roth E, Orusco E, Javoise S, Fort J, Lavergne C, Arnaud C, Rozenberg P, Vayssière C; Groupe de Recherche en Obstétrique rt Gynécologie. Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trial. Am J Obstet Gynecol. 2021 Apr 19:S0002-9378(21)00456-7. doi: 10.1016/j.ajog.2021.04.226.
     
  4. Gély CA, Lacroix MZ, Morin M, Vayssière C, Gayrard V, Picard-Hagen N. Comparison of the materno-fetal transfer of fifteen structurally related bisphenol analogues using an ex vivo human placental perfusion model. Chemosphere. 2021 Aug;276:130213. doi: 10.1016/j.chemosphere.2021.130213.
     
  5. Guerby P, Tasta O, Swiader A, Pont F, Bujold E, Parant O, Vayssière C, Salvayre R, Negre-Salvayre A. Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 2021 Apr;40:101861. doi: 10.1016/j.redox.2021.101861.
     
  6. Klein J, Buffin-Meyer B, Boizard F, Moussaoui N, Lescat O, Breuil B, Fedou C, Feuillet G, Casemayou A, Neau E, Hindryckx A, Decatte L, Levtchenko E, Raaijmakers A, Vayssière C, Goua V, Lucas C, Perrotin F, Cloarec S, Benachi A, Manca-Pellissier MC, Delmas HL, Bessenay L, Le Vaillant C, Allain-Launay E, Gondry J, Boudailliez B, Simon E, Prieur F, Lavocat MP, Saliou AH, De Parscau L, Bidat L, Noel C, Floch C, Bourdat-Michel G, Favre R, Weingertner AS, Oury JF, Baudouin V, Bory JP, Pietrement C, Fiorenza M, Massardier J, Kessler S, Lounis N, Auriol FC, Marcorelles P, Collardeau-Frachon S, Zürbig P, Mischak H, Magalhães P, Batut J, Blader P, Saulnier Blache JS, Bascands JL, Schaefer F, Decramer S, Schanstra JP; BIOMAN consortium. Amniotic fluid peptides predict postnatal kidney survival in developmental kidney disease. Kidney Int. 2021 Mar;99(3):737-749. doi: 10.1016/j.kint.2020.06.043.
     
  7. Laine K, Yli BM, Cole V, Schwarz C, Kwee A, Ayres-de-Campos D, Vayssiere C, Roth E, Gliozheni E, Savochkina Y, Ivanisevic M, Kalis V, Timonen S, Verspyck E, Anstaklis P, Beke A, Eriksen BH, Santo S, Kavsek G, Duvekot H, Dadak C. European guidelines on perinatal care- Peripartum care Episiotomy. J Matern Fetal Neonatal Med. 2021 Dec 12:1-6. doi: 10.1080/14767058.2021.2005022. Epub ahead of print.
     
  8. Lorthe E, Letouzey M, Torchin H, Foix L'Helias L, Gras-Le Guen C, Benhammou V, Boileau P, Charlier C, Kayem G; EPIPAGE-2 Obstetric Writing Group. Antibiotic prophylaxis in preterm premature rupture of membranes at 24-31 weeks' gestation: Perinatal and 2-year outcomes in the EPIPAGE-2 cohort. BJOG. 2021 Dec 26. doi: 10.1111/1471-0528.17081. Epub ahead of print.
     
  9. Mounie M, Costa N, Gaudineau A, Molinier L, Vayssière C, Derumeaux H. Cost-effectiveness analysis of vaginal misoprostol versus dinoprostone pessary: A non-inferiority large randomized controlled trial in France. Int J Gynaecol Obstet. 2021 Oct 29. doi: 10.1002/ijgo.13999. Epub ahead of print.
     
  10. Pierrat V, Marchand-Martin L, Marret S, Arnaud C, Benhammou V, Cambonie G, Debillon T, Dufourg MN, Gire C, Goffinet F, Kaminski M, Lapillonne A, Morgan AS, Rozé JC, Twilhaar S, Charles MA, Ancel PY; EPIPAGE-2 writing group (Vayssière C collaborator). Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study. BMJ. 2021 Apr 28;373:n741. doi: 10.1136/bmj.n741.
     
  11. Schmitz T, Korb D, Azria E, Garabédian C, Rozenberg P, Sénat MV, Sentilhes L, Vayssière C, Winer N, Goffinet F; JUmeaux MODe d'Accouchement (JUMODA) Study Group and the Groupe de Recherche en Obstétrique et Gynécologie (GROG). Perinatal outcome after planned vaginal delivery in monochorionic compared with dichorionic twin pregnancy. Ultrasound Obstet Gynecol. 2021 Apr;57(4):592-599. doi: 10.1002/uog.23518.
     
  12. Sentilhes L, Sénat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, Verspyck E, Fuchs F, Azria E, Gallot D, Korb D, Desbrière R, Le Ray C, Chauleur C, de Marcillac F, Perrotin F, Parant O, Salomon LJ, Gauchotte E, Bretelle F, Sananès N, Bohec C, Mottet N, Legendre G, Letouzey V, Haddad B, Vardon D, Madar H, Mattuizzi A, Daniel V, Regueme S, Roussillon C, Benard A, Georget A, Darsonval A, Deneux-Tharaux C; Groupe de Recherche en Obstétrique et Gynécologie (Vayssière C collaborator). Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery. N Engl J Med. 2021 Apr 29;384(17):1623-1634. doi: 10.1056/NEJMoa2028788.
     
  13. Tasta O, Swiader A, Grazide MH, Rouahi M, Parant O, Vayssière C, Bujold E, Salvayre R, Guerby P, Negre-Salvayre A. A role for 4-hydroxy-2-nonenal in premature placental senescence in preeclampsia and intrauterine growth restriction. Free Radic Biol Med. 2021 Feb 20;164:303-314. doi: 10.1016/j.freeradbiomed.2021.01.002.
     
  14. Tasta O, Parant O, Hamdi SM, Allouche M, Vayssiere C, Guerby P. Evaluation of the Prognostic Value of the sFlt-1/PlGF Ratio in Early-Onset Preeclampsia. Am J Perinatol. 2021 Aug;38(S 01):e292-e298. doi: 10.1055/s-0040-1709696.
     
  15. Tosello B, Garbi A, Blanc J, Lorthe E, Foix-L'Hélias L, D'Ercole C, Winer N, Subtil D, Goffinet F, Kayem G, Resseguier N, Gire C; EPIPAGE-2 Obstetric Writing Group (Vayssière C collaborator). The impact of chorionicity on pregnancy outcome and neurodevelopment at 2 years old among twins born preterm: the EPIPAGE-2 cohort study. BJOG. 2021 Jan;128(2):281-291. doi: 10.1111/1471-0528.16170.
     
  16. Verspyck E, Senat MV, Subtil D, Vayssiere C; Comité de pilotage du groupe des RPC 'Courbes de croissance' du CNGOF. Réponse de E. Verspyck et al. à la correspondance de R. Bessis et al. à propos de la Tribune Libre de E. Verspyck et al. : « Quel référentiel de courbe de croissance fœtale faut-il dorénavant choisir pour notre pays? » Gynécologie-Obstétrique Fertilité & Sénologie2021: 49 (11) S246871892100129X.https://doi.org/10.1016/j.gofs.2021.05.001 [E. Verspyck et al. in response to the correspondence by R. Bessis et al. about the Opinion by E. Verspyck et al.: Which fetal growth curve reference should be now chosen for our country? Gynécologie-Obstétrique Fertilité & Sénologie 2021; 49 (10): S246871892100129X. https://doi.org/10.1016/j.gofs.2021.05.001]. Gynecol Obstet Fertil Senol. 2021 Nov;49(11):876-877. French. doi: 10.1016/j.gofs.2021.06.007.
     
  17. Verspyck E, Senat MV, Subtil D, Vayssiere C; Comité de pilotage du groupe des RPC 'Courbes de croissance' du CNGOF. Quel référentiel de courbe de croissance fœtale faut-il dorénavant choisir pour notre pays ? [Which fetal growth curve reference should be now chosen for our country?]. Gynecol Obstet Fertil Senol. 2021 Oct;49(10):801-802. French. doi: 10.1016/j.gofs.2021.05.001.
     
  18. Writing group:, Nunes I, Dupont C, Timonen S; Guideline panel:, Ayres de Campos D, Cole V, Schwarz C, Kwee A, Yli B, Vayssiere C, Roth GE, Gliozheni E, Savochkina Y, Ivanisevic M, Janku P, Timonen S, Daskalakis G, Beke A, Santo S, Druškovič M, Duvekot JJ, Farr A, Dreyfus M. European Guidelines on Perinatal Care - Oxytocin for induction and augmentation of labor[Formula: see text]. J Matern Fetal Neonatal Med. 2021 Sep 1:1-7. doi: 10.1080/14767058.2021.1945577. Epub ahead of print.

2020

  1. Cadoret F, Guerby P, Cavaignac-Vitalis M, Vayssière C, Parant O, Vidal F. Expectant management in HELLP syndrome: predictive factors of disease evolution [published online ahead of print, 2020 Mar 9]. J Matern Fetal Neonatal Med. 2020;1‐6. doi:10.1080/14767058.2019.1702956.
     
  2. Delorme P, Kayem G, Lorthe E, Sentilhes L, Zeitlin J, Subtil D, Rozé JC, Vayssière C, Durox M, Ancel PY, Pierrat V, Goffinet F; EPIPAGE-2 Obstetric Writing Group. Neurodevelopment at 2 years and umbilical artery Doppler in cases of very preterm birth after prenatal hypertensive disorder or suspected fetal growth restriction: EPIPAGE-2 prospective population-based cohort study. Ultrasound Obstet Gynecol. 2020 Oct;56(4):557-565. doi: 10.1002/uog.22025.
     
  3. Deruelle P, Lelorain S, Deghilage S, Couturier E, Guilbert E, Berveiller P, Sénat MV, Vayssière C, Sentilhes L, Perrotin F, Gallot D, Chauleur C, Sananes N, Roth E, Luton D, Caputo M, Lorio E, Chatelet C, Couster J, Timbely O, Doret-Dion M, Duhamel A, Pigeyre M. Rationale and design of ePPOP-ID: a multicenter randomized controlled trial using an electronic-personalized program for obesity in pregnancy to improve delivery. BMC Pregnancy Childbirth. 2020 Oct 7;20(1):602. doi: 10.1186/s12884-020-03288-x.
     
  4. Frange P, Tubiana R, Sibiude J, Canestri A, Arvieux C, Brunet-Cartier C, Cotte L, Reynes J, Mandelbrot L, Warszawski J, Le Chenadec J, ANRS EPF CO1/CO11 Study Group (Vayssière C collaborator). Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?. J Antimicrob Chemother. 2020;75(5):1324‐1331. doi: 10.1093/jac/dkaa017.
     
  5. Guerby P, Sartor A, Vidal F, Vayssière C. Selective feticide as a treatment of severe preeclampsia in discordant twins. J Gynecol Obstet Hum Reprod. 2020 Jan;49(1):101633. doi: 10.1016/j.jogoh.2019.101633.
     
  6. Guillard A, Gaultier E, Cartier C, Devoille L, Noireaux J, Chevalier L, Morin M, Grandin F, Lacroix MZ, Coméra C, Cazanave A, de Place A, Gayrard V, Bach V, Chardon K, Bekhti N, Adel-Patient K, Vayssière C, Fisicaro P, Feltin N, de la Farge F, Picard-Hagen N, Lamas B, Houdeau E. Basal Ti level in the human placenta and meconium and evidence of a materno-foetal transfer of food-grade TiO2 nanoparticles in an ex vivo placental perfusion model. Part Fibre Toxicol. 2020 Oct 7;17(1):51. doi: 10.1186/s12989-020-00381-z.
     
  7. Kayem G, Alessandrini V, Azria E, Blanc J, Bohec C, Bornes M, Bretelle F, Ceccaldi PF, Chalet Y, Chauleur C , Cordier AG, Deruelle P, Desbrière R, Doret M, Dreyfus M, Driessen M, Fermaut M, Gallot D, Garabédian C, Huissoud C, Lecarpentier E, Luton D, Morel O, Perrotin F, Picone O, Rozenberg P, Schmitz T, Sentilhes L, Sroussi J, Vayssière C, Verspyck E, Vivanti AJ, Winer N. A snapshot of the Covid-19 pandemic among pregnant women in France [published online ahead of print, 2020 Jun 4]. J Gynecol Obstet Hum Reprod. 2020;101826. doi: 10.1016/j.jogoh.2020.101826.
     
  8. Kerbage Y, Senat MV, Drumez E, Subtil D, Vayssière C, Deruelle P. Risk factors for failed induction of labor among pregnant women with Class III obesity. Acta Obstet Gynecol Scand. 2020;99(5):637‐643. doi: 10.1111/aogs.13794.
     
  9. Loussert L, Vidal F, Parant O, Hamdi SM, Vayssière C, Guerby P. Aspirin for prevention of preeclampsia and fetal growth restriction [published online ahead of print, 2020 Jan 18]. Prenat Diagn. 2020;10.1002/pd.5645. doi: 10.1002/pd.5645.
     
  10. Maisonneuve E, Lorthe E, Torchin H, Delorme P, Devisme L, L'Hélias LF, Marret S, Subtil D, Bodeau-Livinec F, Pierrat V, Sentilhes L, Goffinet F, Ancel PY, Kayem G; EPIPAGE-2 Obstetric writing group (Vayssière C, Arnaud C collaborators). . Association of Chorioamnionitis with Cerebral Palsy at Two Years after Spontaneous Very Preterm Birth: The EPIPAGE-2 Cohort Study. J Pediatr. 2020 Jul;222:71-78.e6. doi: 10.1016/j.jpeds.2020.03.021.
     
  11. Minville V, Vidal F, Loutrel O, Castel A, Jacques L, Vayssière C, Parant O, Guerby P, Asehnoune K. Identifying predictive factors for admitting patients with severe pre-eclampsia to intensive care unit. J Matern Fetal Neonatal Med. 2020 Sep 8:1-7. doi: 10.1080/14767058.2020.1814248.
     
  12. Morin M, Claris O, Dussart C, Frelat A, De Place A, Molinier L, Matillon Y, Ehlinger V, Vayssière C. Quality of Life During Pregnancy: Is There a Link with Breastfeeding at Birth?. Breastfeed Med. 2020;15(5):321‐330. doi: 10.1089/bfm.2019.0123.
     
  13. Pauphilet V, Goffinet F, Seco A, Azria E, Cordier AG, Deruelle P, Kayem G, Rozenberg P, Sananès N, Sénat MV, Sentilhes L, Vayssière C, Winer N, Korb D, Schmitz T, JUmeaux MODe dʼAccouchement (JUMODA) Study Group and the Groupe de Recherche en Obstétrique et Gynécologie (GROG). Internal Version Compared With Pushing for Delivery of Cephalic Second Twins. Obstet Gynecol. 2020;135(6):1435‐1443. doi: 10.1097/AOG.0000000000003862.
     
  14. Peyronnet V, Sibiude J, Huissoud C, Lescure FX, Lucet JC, Mandelbrot L, Nisand I, Belaish-Allart J, Vayssière C, Yazpandanah Y, Luton D, Picone O. Infection par le SARS-CoV-2 chez les femmes enceintes. Actualisation de l’état des connaissances et de la proposition de prise en charge. CNGOF [Infection with SARS-CoV-2 in pregnancy. Update of Information and proposed care. CNGOF]. Gynecol Obstet Fertil Senol. 2020 Dec;48(12):858-870. French. doi: 10.1016/j.gofs.2020.10.001.
     
  15. TRAAP2 Study Group and the Groupe de Recherche en Obstétrique et Gynécologie (GROG) (Vayssière C collaborator).. TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol. BMC Pregnancy Childbirth. 2020 Jan 31;20(1):63. doi: 10.1186/s12884-019-2718-4.

    2019
  • Amer-Wåhlin I, Ugwumadu A, Yli BM, Kwee A, Timonen S, Cole V, Ayres-de-Campos D, Roth GE, Schwarz C, Ramenghi LA, Todros T, Ehlinger V, Vayssiere C; Study Group of Intrapartum Fetal Monitoring (European Association of Perinatal Medicine). Fetal electrocardiography ST-segment analysis for intrapartum monitoring: a critical appraisal of conflicting evidence and a way forward. Am J Obstet Gynecol. 2019 Dec;221(6):577-601.e11. doi: 10.1016/j.ajog.2019.04.003.
     
  • Araujo M, Hurault-Delarue C, Bouilhac C, Petiot P, Benevent  J, Vayssière C, Vidal S, Montastruc JL, Damase-Michel  C, Lacroix  I. Non-steroidal anti-inflammatory drug prescriptions from the 6th month of pregnancy: impact of advice from health authorities. Fundam Clin Pharmacol. 2019. 33(5):581–588. doi:10.1111/fcp.12460
     
  • Blanc J, Resseguier N, Goffinet F, Lorthe E, Kayem G, Delorme P, Vayssière C, Auquier P, D'Ercole C. Association between gestational age and severe maternal morbidity and mortality of preterm cesarean delivery: a population-based cohort study. Am J Obstet Gynecol. 2019 Apr;220(4):399.e1-399.e9. doi: 10.1016/j.ajog.2019.01.005.
     
  • Brunello J, Guerby P, Cartoux C, Yazigi A, Baujat M, Parant O, Vayssière C, Chantalat E, Vidal F. Safety considerations regarding Methotrexate off-label use in tubal ectopic pregnancy. Arch Gynecol Obstet. 2019 Oct;300(4):1095-1096. Erratum in: Arch Gynecol Obstet. 2019 Aug 26.
    doi:10.1007/s00404-019-05254-1.
     
  • Brunello J, Guerby P, Cartoux C, Yazigi A, Baujat M, Parant O, Vayssière C, Vaysse C, Chantalat E, Vidal F. Can early βhCG change and baseline progesterone level predict treatment outcome in patients receiving single dose Methotrexate protocol for tubal ectopic pregnancy? Arch Gynecol Obstet. 2019 Mar;299(3):741-745. doi: 10.1007/s00404-019-05068-1.
     
  • Brunello J, Guerby P, Cartoux C, Yazigi A, Baujat M, Parant O, Vayssière C, Chantalat E, Vidal F. Correction to: Safety considerations regarding Methotrexate of label use in tubal ectopic pregnancy. Arch Gynecol Obstet. 2019 Oct;300(4):1097. doi:10.1007/s00404-019-05279-6.
     
  • Brunello J, Guerby P, Cartoux C, Yazigi A, Baujat M, Parant O, Vayssière C, Chantalat E, Vidal F. Early predictive factors of single dose methotrexate outcome in patients with ectopic pregnancy. Arch Gynecol Obstet. 2019;300(3):795. doi: 10.1007/s00404-019-05255-0.
     
  • Grandin FC, Lacroix MZ, Gayrard V, Viguié C, Mila H, de Place A, Vayssière C, Morin M, Corbett J, Gayrard C, Gely CA, Toutain PL, Picard-Hagen N. Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure ? Placental transfer across the perfused human placenta. Chemosphere. 2019 Apr;221:471-478. doi: 10.1016/j.chemosphere.2019.01.065.
     
  • Guerby P, Swiader A, Augé N, Parant O, Vayssière C, Uchida K, Salvayre R, Negre-Salvayre A. High glutathionylation of placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 2019 Apr;22:101126. doi: 10.1016/j.redox.2019.101126.
     
  • Guerby P, Swiader A, Tasta O, Pont F, Rodriguez F, Parant O, Vayssière C, Shibata T, Uchida K, Salvayre R, Negre-Salvayre A. Modification of endothelial nitric oxide synthase by 4-oxo-2(E)-nonenal(ONE) in preeclamptic placentas. Free Radic Biol Med. 2019;141:416–425. doi: 10.1016/j.freeradbiomed.2019.07.015.
     
  • Lorthe E, Sentilhes L, Quere M, Lebeaux C, Winer N, Torchin H, Goffinet F, Delorme P, Kayem G; EPIPAGE-2 Obstetric Writing Group (Arnaud C, Vayssière C collaborators). Planned delivery route of preterm breech singletons, and neonatal and 2-year outcomes: a population-based cohort study. BJOG. 2019 Jan;126(1):73-8 doi: 10.1111/1471-0528.15466.
     
  • Morin M, Claris O, Dussart C, Frelat A, de Place A, Molinier L, Matillon Y, Elhinger V, Vayssiere C. Health-related quality of life during pregnancy: A repeated measures study of changes from the first trimester to birth. Acta Obstet Gynecol Scand. 2019 Oct;98(10):1282-1291. doi: 10.1111/aogs.13624.